United States Biotechnology & Medical Research

OncoSec Medical Inc (ONCS)

Track

Ticker: ONCS Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for OncoSec Medical Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 9 Feb 2023
Value US$256,887.35 | Price 284.07 | Shares 74,889 (-44.3%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-02-09 2023-02-09 S Sale
DelAversano Robert J

VP, Finance

Officer
74,889 -44.3%
284.07
US$256,887 		74,889 -44.3% 284.07 US$256,887
2022-11-04 2022-11-04 S Sale
DelAversano Robert J

VP, Finance

Officer
14,133 +18.2%
47.31
US$951,318 		14,133 +18.2% 47.31 US$951,318
2022-08-05 2022-08-05 S Sale
DelAversano Robert J

VP, Finance

Officer
98,554 -41.4%
294.29
US$66,444 		98,554 -41.4% 294.29 US$66,444
2022-05-06 2022-05-06 S Sale
DelAversano Robert J

VP, Finance

Officer
274 -1.2%
0.83
US$227 		274 -1.2% 0.83 US$227
2022-02-11 2022-02-09 S Sale
DelAversano Robert J

VP, Finance

Officer
409 -1.7%
0.88
US$360 		409 -1.7% 0.88 US$360
2021-11-03 2021-11-01 S Sale
DelAversano Robert J

VP, Finance

Officer
343 -1.4%
1.75
US$600 		343 -1.4% 1.75 US$600
2021-06-29 2021-06-28 S Sale
Leuthner Brian A

Interim CEO

Officer
13,613 -7.1%
3.16
US$43,017 		13,613 -7.1% 3.16 US$43,017
2021-05-04 2021-05-03 S Sale
DelAversano Robert J

VP, Finance

Officer
453 -1.8%
4.86
US$2,202 		453 -1.8% 4.86 US$2,202
2021-05-04 2021-04-30 S Sale
3.3
O'Connor Daniel J.

CEO and President

Executive Director
3,172 -3.2%
4.86
US$15,416 		3,172 -3.2% 4.86 US$15,416
2021-04-26 2021-04-16 B Purchase
China Grand Pharmaceutical & Healthcare Holdings Ltd

See Remarks

Large shareholder
281,968 +9.2%
3.45
US$972,790 		281,968 +9.2% 3.45 US$972,790
2021-04-26 2021-04-16 B Purchase
China Grand Pharmaceutical & Healthcare Holdings Ltd

See Remarks

Large shareholder
1,409,838 +9.2%
3.45
US$4,863,941 		1,409,838 +9.2% 3.45 US$4,863,941
2021-02-02 2021-02-01 S Sale
3.3
O'Connor Daniel J.

CEO and President

Executive Director
3,413 -3.3%
7.71
US$26,314 		3,413 -3.3% 7.71 US$26,314
2021-01-27 2021-01-25 B Purchase
China Grand Pharmaceutical & Healthcare Holdings Ltd

See Remarks

Large shareholder
677,839 +28.2%
5.45
US$3,694,223 		677,839 +28.2% 5.45 US$3,694,223
2021-01-27 2021-01-25 B Purchase
China Grand Pharmaceutical & Healthcare Holdings Ltd

See Remarks

Large shareholder
3,389,198 +28.2%
5.45
US$18,471,129 		3,389,198 +28.2% 5.45 US$18,471,129
2020-11-23 2020-11-20 S Sale
Alpha Holdings, Inc.
Non-Executive Director
80,000 -5.6%
4.92
US$393,872 		80,000 -5.6% 4.92 US$393,872
2020-11-20 2020-11-19 S Sale
Alpha Holdings, Inc.
Non-Executive Director
50,000 -3.4%
5.10
US$255,230 		50,000 -3.4% 5.10 US$255,230
2020-11-19 2020-11-18 S Sale
Alpha Holdings, Inc.
Non-Executive Director
10,999 -0.7%
5.24
US$57,652 		10,999 -0.7% 5.24 US$57,652
2020-11-19 2020-11-18 S Sale
Alpha Holdings, Inc.
Non-Executive Director
40,000 -2.6%
5.24
US$209,664 		40,000 -2.6% 5.24 US$209,664
2020-11-18 2020-11-17 S Sale
Alpha Holdings, Inc.
Non-Executive Director
40,000 -2.5%
5.17
US$206,744 		40,000 -2.5% 5.17 US$206,744
2020-11-18 2020-11-16 S Sale
Alpha Holdings, Inc.
Non-Executive Director
40,000 -2.5%
5.41
US$216,328 		40,000 -2.5% 5.41 US$216,328
2020-11-03 2020-11-02 S Sale
3.3
O'Connor Daniel J.

CEO and President

Executive Director
3,280 -3.1%
3.79
US$12,431 		3,280 -3.1% 3.79 US$12,431
2020-08-21 2020-08-19 B Purchase
China Grand Pharmaceutical & Healthcare Holdings Ltd

See Remarks

Large shareholder
399,800 +20.0%
3.25
US$1,299,350 		399,800 +20.0% 3.25 US$1,299,350
2020-08-21 2020-08-19 B Purchase
China Grand Pharmaceutical & Healthcare Holdings Ltd

See Remarks

Large shareholder
1,999,000 +20.0%
3.25
US$6,496,750 		1,999,000 +20.0% 3.25 US$6,496,750
2020-08-04 2020-07-31 S Sale
3.3
O'Connor Daniel J.

CEO and President

Executive Director
3,133 -2.9%
4.20
US$13,159 		3,133 -2.9% 4.20 US$13,159
2020-05-04 2020-04-30 S Sale
3.3
O'Connor Daniel J.

CEO and President

Executive Director
3,075 -4.7%
1.79
US$5,504 		3,075 -4.7% 1.79 US$5,504
2020-02-03 2020-01-31 S Sale
3.3
O'Connor Daniel J.

CEO and President

Executive Director
2,654 -3.9%
1.96
US$5,202 		2,654 -3.9% 1.96 US$5,202
2020-01-21 2020-01-16 S Sale
2.8
Bonstein Sara

CFO/COO
1,351 -3.2%
2.08
US$2,810 		1,351 -3.2% 2.08 US$2,810
2019-11-01 2019-10-31 S Sale
3.3
O'Connor Daniel J.

CEO and President

Executive Director
2,128 -3.0%
2.16
US$4,596 		2,128 -3.0% 2.16 US$4,596
2019-10-18 2019-10-16 S Sale
2.8
Bonstein Sara

CFO/COO
1,111 -2.5%
2.01
US$2,233 		1,111 -2.5% 2.01 US$2,233
2019-07-19 2019-07-17 B Purchase
Alpha Holdings, Inc.
Large shareholder
30,000 +1.9%
2.57
US$77,100 		30,000 +1.9% 2.57 US$77,100
2019-07-17 2019-07-16 B Purchase
Alpha Holdings, Inc.
Large shareholder
60,000 +3.9%
2.34
US$140,400 		60,000 +3.9% 2.34 US$140,400
2019-07-17 2019-07-15 B Purchase
Alpha Holdings, Inc.
Large shareholder
30,000 +2.0%
2.22
US$66,600 		30,000 +2.0% 2.22 US$66,600
2019-05-24 2019-05-22 B Purchase
Alpha Holdings, Inc.
Large shareholder
491,000 +4.9%
3.14
US$1,541,740 		491,000 +4.9% 3.14 US$1,541,740
2018-11-26 2018-11-20 B Purchase DEMESA JAMES M Non-Executive Director
7,000 +50.0%
0.80
US$5,600 		7,000 +50.0% 0.80 US$5,600
2018-11-26 2018-11-07 B Purchase DEMESA JAMES M Non-Executive Director
1,500 +12.0%
0.91
US$1,365 		1,500 +12.0% 0.91 US$1,365
2018-11-07 2018-11-07 B Purchase O'Connor Daniel J.

CEO & President

Executive Director
10,000 +60.0%
0.91
US$9,100 		10,000 +60.0% 0.91 US$9,100
2018-07-06 2018-07-05 S Sale DHILLON PUNIT Non-Executive Director
45,785 -8.6%
1.31
US$60,070 		45,785 -8.6% 1.31 US$60,070
2018-07-06 2018-07-05 S Sale SLANSKY RICHARD B

Chief Financial Officer

Officer
6,725 -2.4%
1.31
US$8,823 		6,725 -2.4% 1.31 US$8,823
2018-07-06 2018-07-05 S Sale
DHILLON AVTAR S
Non-Executive Director
3,100 -2.1%
1.31
US$4,067 		3,100 -2.1% 1.31 US$4,067
2018-07-06 2018-06-29 S Sale DHILLON PUNIT Non-Executive Director
5,401 -1.0%
1.38
US$7,453 		5,401 -1.0% 1.38 US$7,453
2018-07-06 2018-06-29 S Sale SLANSKY RICHARD B

Chief Financial Officer

Officer
2,420 -0.9%
1.38
US$3,340 		2,420 -0.9% 1.38 US$3,340
2018-07-06 2018-06-29 S Sale
DHILLON AVTAR S
Non-Executive Director
1,066 -0.7%
1.38
US$1,471 		1,066 -0.7% 1.38 US$1,471
2018-07-06 2018-06-28 S Sale DHILLON PUNIT Non-Executive Director
7,882 -1.4%
1.40
US$11,043 		7,882 -1.4% 1.40 US$11,043
2018-07-06 2018-06-28 S Sale SLANSKY RICHARD B

Chief Financial Officer

Officer
3,532 -1.2%
1.40
US$4,948 		3,532 -1.2% 1.40 US$4,948
2018-07-06 2018-06-28 S Sale
DHILLON AVTAR S
Non-Executive Director
1,556 -1.0%
1.40
US$2,180 		1,556 -1.0% 1.40 US$2,180
2018-07-06 2018-06-27 S Sale DHILLON PUNIT Non-Executive Director
17,480 -3.1%
1.37
US$24,018 		17,480 -3.1% 1.37 US$24,018
2018-07-06 2018-06-27 S Sale
SLANSKY RICHARD B

Chief Financial Officer

Officer
7,832 -2.7%
1.37
US$10,761 		7,832 -2.7% 1.37 US$10,761
2018-07-06 2018-06-27 S Sale DHILLON AVTAR S Non-Executive Director
3,451 -2.3%
1.37
US$4,742 		3,451 -2.3% 1.37 US$4,742
2018-07-06 2018-06-26 S Sale DHILLON PUNIT Non-Executive Director
23,820 -4.1%
1.40
US$33,300 		23,820 -4.1% 1.40 US$33,300
2018-07-06 2018-06-26 S Sale SLANSKY RICHARD B

Chief Financial Officer

Officer
10,673 -3.5%
1.40
US$14,921 		10,673 -3.5% 1.40 US$14,921
2018-07-06 2018-06-26 S Sale DHILLON AVTAR S Non-Executive Director
4,703 -3.0%
1.40
US$6,575 		4,703 -3.0% 1.40 US$6,575
2018-07-06 2018-06-25 S Sale DHILLON PUNIT Non-Executive Director
1,021 -0.2%
1.41
US$1,435 		1,021 -0.2% 1.41 US$1,435
2018-07-06 2018-06-25 S Sale SLANSKY RICHARD B

Chief Financial Officer

Officer
458 -0.2%
1.41
US$643 		458 -0.2% 1.41 US$643
2018-07-06 2018-06-25 S Sale DHILLON AVTAR S Non-Executive Director
202 -0.1%
1.41
US$284 		202 -0.1% 1.41 US$284
2018-07-06 2018-06-22 S Sale DHILLON PUNIT Non-Executive Director
14,976 -2.5%
1.42
US$21,236 		14,976 -2.5% 1.42 US$21,236
2018-07-06 2018-06-22 S Sale SLANSKY RICHARD B

Chief Financial Officer

Officer
6,710 -2.2%
1.42
US$9,515 		6,710 -2.2% 1.42 US$9,515
2018-07-06 2018-06-22 S Sale DHILLON AVTAR S Non-Executive Director
2,956 -1.8%
1.42
US$4,192 		2,956 -1.8% 1.42 US$4,192
2018-07-06 2018-06-21 S Sale DHILLON PUNIT Non-Executive Director
11,035 -1.8%
1.40
US$15,460 		11,035 -1.8% 1.40 US$15,460
2018-07-06 2018-06-21 S Sale SLANSKY RICHARD B

Chief Financial Officer

Officer
4,944 -1.6%
1.40
US$6,927 		4,944 -1.6% 1.40 US$6,927
2018-07-06 2018-06-21 S Sale DHILLON AVTAR S Non-Executive Director
2,178 -1.3%
1.40
US$3,051 		2,178 -1.3% 1.40 US$3,051
2018-07-06 2018-06-20 S Sale DHILLON PUNIT Non-Executive Director
55,585 -8.3%
1.42
US$79,042 		55,585 -8.3% 1.42 US$79,042
2018-07-06 2018-06-20 S Sale SLANSKY RICHARD B

Chief Financial Officer

Officer
24,906 -7.4%
1.42
US$35,416 		24,906 -7.4% 1.42 US$35,416
2018-07-06 2018-06-20 S Sale DHILLON AVTAR S Non-Executive Director
10,973 -6.3%
1.42
US$15,604 		10,973 -6.3% 1.42 US$15,604
2018-07-06 2018-06-19 S Sale DHILLON PUNIT Non-Executive Director
9,310 -1.4%
1.36
US$12,699 		9,310 -1.4% 1.36 US$12,699
2018-07-06 2018-06-19 S Sale SLANSKY RICHARD B

Chief Financial Officer

Officer
4,171 -1.2%
1.36
US$5,689 		4,171 -1.2% 1.36 US$5,689
2018-07-06 2018-06-19 S Sale DHILLON AVTAR S Non-Executive Director
1,838 -1.0%
1.36
US$2,507 		1,838 -1.0% 1.36 US$2,507
2018-07-06 2018-06-18 S Sale DHILLON PUNIT Non-Executive Director
28,145 -4.0%
1.39
US$39,009 		28,145 -4.0% 1.39 US$39,009
2018-07-06 2018-06-18 S Sale SLANSKY RICHARD B

Chief Financial Officer

Officer
12,613 -3.6%
1.39
US$17,482 		12,613 -3.6% 1.39 US$17,482
2018-07-06 2018-06-18 S Sale DHILLON AVTAR S Non-Executive Director
5,552 -3.1%
1.39
US$7,695 		5,552 -3.1% 1.39 US$7,695
2018-02-06 2018-02-06 PP Planned purchase DHILLON PUNIT

President

Executive Director
3,000 +1.3%
0.88
US$2,640 		3,000 +1.3% 0.88 US$2,640
2018-02-06 2018-02-05 B Purchase O'Connor Daniel J.

CEO

Executive Director
16,667 +inf%
1.50
US$25,000 		16,667 +inf% 1.50 US$25,000
2017-08-02 2017-07-31 PP Planned purchase DHILLON PUNIT

President and CEO

Executive Director
3,000 +1.3%
0.88
US$2,640 		3,000 +1.3% 0.88 US$2,640
2017-08-02 2017-07-31 PP Planned purchase Mohan-Peterson Sheela

Chief Legal&Compliance Officer
3,000 +46.0%
0.88
US$2,640 		3,000 +46.0% 0.88 US$2,640
2017-02-02 2017-01-31 PP Planned purchase Mohan-Peterson Sheela

Chief Legal&Compliance Officer
3,000 +85.2%
0.99
US$2,970 		3,000 +85.2% 0.99 US$2,970
2017-02-02 2017-01-31 PP Planned purchase DHILLON PUNIT

President and CEO
3,000 +1.4%
0.99
US$2,970 		3,000 +1.4% 0.99 US$2,970
Explore more

More insider trading research around OncoSec Medical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America